NCT01935908

Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study

Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Vanderbilt University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the feasibility of prospectively enrolling and randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam or not to receive levetiracetam, and documenting in-hospital and follow-up clinical variables.

Conditions

• Subarachnoid Hemorrhage
• Seizures

Interventions

Type	Name	Description
DRUG	levetiracetam

Timeline

• Start date: 2013-05-01
• Primary completion: 2013-05-01
• Completion: 2013-05-01
• First posted: 2013-09-05
• Last updated: 2017-11-01

Locations

1 site across 1 country: United States